1 – 10 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- A physiologically based pharmacokinetic perspective on the clinical utility of albumin-based dose adjustments in critically ill patients
- 2017
- A novel scale linking potency and dosage to estimate anticholinergic exposure in older adults : the Muscarinic Acetylcholinergic Receptor ANTagonist Exposure Scale
- Influence of Bayesian optimization on the performance of propofol target-controlled infusion
- Prophylactic atropine administration attenuates the negative haemodynamic effects of induction of anaesthesia with propofol and high-dose remifentanil : a randomised controlled trial
- Comparative population pharmacokinetics and absolute oral bioavailability of COX-2 selective inhibitors celecoxib, mavacoxib and meloxicam in cockatiels (Nymphicus hollandicus)
- The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
- Dexmedetomidine pharmacokineticpharmacodynamic modelling in healthy volunteers, 1 : influence of arousal on bispectral index and sedation
- Pharmacokinetic interactions between simeprevir and ledipasvir in treatment naive hepatitis C virus genotype 1-Infected patients without cirrhosis treated with a simeprevir-sofosbuvir-ledipasvir regimen
- PBPK in preterm and term neonates : a review
- 2016
- What about confidence intervals? : a word of caution when interpreting PTA simulations